$CTIC Company News Insider filings one way to
Post# of 72711
Posted On: 10/20/2014 10:02:13 AM
$CTIC Company News
Insider filings one way to track tricky micro-cap biotechs 12:14 p.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 4:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 7:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 4:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 8:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 7:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 6:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 4:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 10:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 5:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 11:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 5:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 5:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 2:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 5:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 5:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 4:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 9:09 a.m. June 30, 2011 - MarketWatch.com
InsiderInsights.com Daily Round Up 9/24/14: Mercer International, OPKO Health, New Media, CTI BioPharma 8:17 a.m. Sept. 25, 2014 - Seeking Alpha
Merrimack Does Well to License Marginal Cancer Drug to Baxter 8:14 a.m. Sept. 24, 2014 - TheStreet.com
CTI BioPharma and Servier collaborate on cancer drug 8:19 a.m. Sept. 17, 2014 - Seeking Alpha
SEC Slaps Biotech Hedge Fund for Short-Selling Violations 1:04 p.m. Sept. 16, 2014 - TheStreet.com
CTI BioPharma set for gap up at the open 8:00 a.m. Sept. 9, 2014 - Seeking Alpha
Insider Trading Alert - MTDR, ABCO And CTIC Traded By Insiders 10:15 a.m. Aug. 18, 2014 - TheStreet.com
Insider Trading Alert - CMS, CTIC And WFT Traded By Insiders 10:15 a.m. Aug. 7, 2014 - TheStreet.com
CTI BioPharma's (CTIC) CEO Jim Bianco on Q2 2014 Results - Earnings Call Transcript 10:56 p.m. Aug. 4, 2014 - Seeking Alpha
10-Q: CTI BIOPHARMA CORP 5:07 p.m. Aug. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
CTI BioPharma (CTIC) Q2 2014 Results - Earnings Call Webcast 4:25 p.m. Aug. 4, 2014 - Seeking Alpha
Insider Trading Alert - AAWW, CTIC And HBI Traded By Insiders 10:12 a.m. July 10, 2014 - TheStreet.com
$4 Or Less: 2 Small Biotechs Moving On News 11:56 a.m. July 2, 2014 - Seeking Alpha
CTI completes clinical trial enrollment that sets up a milestone payment 7:23 a.m. July 1, 2014 - Seeking Alpha
Insider Trading Alert - FII, RP And CTIC Traded By Insiders 10:30 a.m. June 30, 2014 - TheStreet.com
Insider Trading Alert - FII, RP And CTIC Traded By Insiders 10:23 a.m. June 30, 2014 - TheStreet.com
Insider Trading Alert - MWE, CPT And CTIC Traded By Insiders 10:16 a.m. June 9, 2014 - TheStreet.com
Name change for Cell Therapeutics 7:12 a.m. May 30, 2014 - Seeking Alpha
Thirteen Analyst Stocks Under $10 With Big Upside Calls 8:23 a.m. May 24, 2014 - 247WallSt.com
Why Cell Therapeutics (CTIC) Stock Is Spiking Today 12:27 p.m. May 22, 2014 - TheStreet.com
Interesting CTIC Put And Call Options For July 19th 10:51 a.m. May 20, 2014 - TheStreet.com
CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 1:30 a.m. Today - PR Newswire - PRF
Technical Updates on Health Care Sector Stocks - AstraZeneca, Novartis, Salix Pharma, Inovio Pharma, and CTI BioPharma 9:15 a.m. Oct. 6, 2014 - PR Newswire - PRF
CTI BioPharma And Servier Announce Exclusive License And Collaboration Agreement To Develop And Commercialize PIXUVRI® 1:30 a.m. Sept. 17, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Exact Sciences, BioCryst Pharma, Spectrum Pharma, Aeterna Zentaris, and CTI BioPharma 8:50 a.m. Aug. 25, 2014 - PR Newswire - PRF
FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis 1:30 a.m. Aug. 7, 2014 - PR Newswire - PRF
CTI BioPharma Reports Second Quarter 2014 Financial Results 4:01 p.m. Aug. 4, 2014 - PR Newswire - PRF
The Federal Reserve Playing Analyst Damaging to Biotechnology Companies 10:06 a.m. July 30, 2014 - ACCESSWIRE
CTI BioPharma to Report Second Quarter 2014 Financial Results on August 4, 2014 1:30 a.m. July 28, 2014 - PR Newswire - PRF
CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands 1:30 a.m. July 21, 2014 - PR Newswire - PRF
Acquisitions, Study Results, Merger Agreements, and Completed Trial Recruitments - Analyst Notes on Cooper, Agenus, Transcept, CTI and ANI 6:00 a.m. July 4, 2014 - PR Newswire - PRF
CTI BioPharma Completes Recruitment in PERSIST-1 Pivotal Phase 3 Trial of Pacritinib for Patients with Myelofibrosis 1:30 a.m. July 1, 2014 - PR Newswire - PRF
Biotech Stocks on the Move -- Research on CTI BioPharma, BioMarin Pharma, Vertex Pharma, and Northwest Biotherapeutics 7:00 a.m. June 27, 2014 - PR Newswire - PRF
Approvals, Agreements, Name Change, and Partnerships - Analyst Notes on Johnson & Johnson, Furiex Pharmaceuticals, Select Medical, CTI and Hill-Rom 6:00 a.m. June 13, 2014 - PR Newswire - PRF
CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Initiates Randomized Phase 2 Trial Evaluating Tosedostat plus Cytarabine for Older Patients with AML or High-Risk MDS 1:30 a.m. June 12, 2014 - PR Newswire - PRF
Cell Therapeutics, Inc. Announces Change of Name to CTI BioPharma Corp. 1:30 a.m. May 30, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Cell Therapeutics, Inc. Regarding Possible Breaches of Fiduciary Duty 12:52 p.m. May 29, 2014 - PR Newswire - PRF
CollabRx's Mobile App Simplifies Cancer Treatment Options 10:46 a.m. May 29, 2014 - ACCESSWIRE
Cell Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference 1:30 a.m. May 29, 2014 - PR Newswire - PRF
Top Gainers on the Move -- Research on Aeropostale, FirstEnergy, Cell Therapeutics, and Dyax 5:00 a.m. May 28, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma 9:15 a.m. May 6, 2014 - PR Newswire - PRF
Insider filings one way to track tricky micro-cap biotechs 12:14 p.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 4:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 7:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 4:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 8:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 7:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 6:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 4:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 10:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 5:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 11:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 5:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 5:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 2:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 5:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 5:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 4:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 9:09 a.m. June 30, 2011 - MarketWatch.com
InsiderInsights.com Daily Round Up 9/24/14: Mercer International, OPKO Health, New Media, CTI BioPharma 8:17 a.m. Sept. 25, 2014 - Seeking Alpha
Merrimack Does Well to License Marginal Cancer Drug to Baxter 8:14 a.m. Sept. 24, 2014 - TheStreet.com
CTI BioPharma and Servier collaborate on cancer drug 8:19 a.m. Sept. 17, 2014 - Seeking Alpha
SEC Slaps Biotech Hedge Fund for Short-Selling Violations 1:04 p.m. Sept. 16, 2014 - TheStreet.com
CTI BioPharma set for gap up at the open 8:00 a.m. Sept. 9, 2014 - Seeking Alpha
Insider Trading Alert - MTDR, ABCO And CTIC Traded By Insiders 10:15 a.m. Aug. 18, 2014 - TheStreet.com
Insider Trading Alert - CMS, CTIC And WFT Traded By Insiders 10:15 a.m. Aug. 7, 2014 - TheStreet.com
CTI BioPharma's (CTIC) CEO Jim Bianco on Q2 2014 Results - Earnings Call Transcript 10:56 p.m. Aug. 4, 2014 - Seeking Alpha
10-Q: CTI BIOPHARMA CORP 5:07 p.m. Aug. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
CTI BioPharma (CTIC) Q2 2014 Results - Earnings Call Webcast 4:25 p.m. Aug. 4, 2014 - Seeking Alpha
Insider Trading Alert - AAWW, CTIC And HBI Traded By Insiders 10:12 a.m. July 10, 2014 - TheStreet.com
$4 Or Less: 2 Small Biotechs Moving On News 11:56 a.m. July 2, 2014 - Seeking Alpha
CTI completes clinical trial enrollment that sets up a milestone payment 7:23 a.m. July 1, 2014 - Seeking Alpha
Insider Trading Alert - FII, RP And CTIC Traded By Insiders 10:30 a.m. June 30, 2014 - TheStreet.com
Insider Trading Alert - FII, RP And CTIC Traded By Insiders 10:23 a.m. June 30, 2014 - TheStreet.com
Insider Trading Alert - MWE, CPT And CTIC Traded By Insiders 10:16 a.m. June 9, 2014 - TheStreet.com
Name change for Cell Therapeutics 7:12 a.m. May 30, 2014 - Seeking Alpha
Thirteen Analyst Stocks Under $10 With Big Upside Calls 8:23 a.m. May 24, 2014 - 247WallSt.com
Why Cell Therapeutics (CTIC) Stock Is Spiking Today 12:27 p.m. May 22, 2014 - TheStreet.com
Interesting CTIC Put And Call Options For July 19th 10:51 a.m. May 20, 2014 - TheStreet.com
CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 1:30 a.m. Today - PR Newswire - PRF
Technical Updates on Health Care Sector Stocks - AstraZeneca, Novartis, Salix Pharma, Inovio Pharma, and CTI BioPharma 9:15 a.m. Oct. 6, 2014 - PR Newswire - PRF
CTI BioPharma And Servier Announce Exclusive License And Collaboration Agreement To Develop And Commercialize PIXUVRI® 1:30 a.m. Sept. 17, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Exact Sciences, BioCryst Pharma, Spectrum Pharma, Aeterna Zentaris, and CTI BioPharma 8:50 a.m. Aug. 25, 2014 - PR Newswire - PRF
FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis 1:30 a.m. Aug. 7, 2014 - PR Newswire - PRF
CTI BioPharma Reports Second Quarter 2014 Financial Results 4:01 p.m. Aug. 4, 2014 - PR Newswire - PRF
The Federal Reserve Playing Analyst Damaging to Biotechnology Companies 10:06 a.m. July 30, 2014 - ACCESSWIRE
CTI BioPharma to Report Second Quarter 2014 Financial Results on August 4, 2014 1:30 a.m. July 28, 2014 - PR Newswire - PRF
CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands 1:30 a.m. July 21, 2014 - PR Newswire - PRF
Acquisitions, Study Results, Merger Agreements, and Completed Trial Recruitments - Analyst Notes on Cooper, Agenus, Transcept, CTI and ANI 6:00 a.m. July 4, 2014 - PR Newswire - PRF
CTI BioPharma Completes Recruitment in PERSIST-1 Pivotal Phase 3 Trial of Pacritinib for Patients with Myelofibrosis 1:30 a.m. July 1, 2014 - PR Newswire - PRF
Biotech Stocks on the Move -- Research on CTI BioPharma, BioMarin Pharma, Vertex Pharma, and Northwest Biotherapeutics 7:00 a.m. June 27, 2014 - PR Newswire - PRF
Approvals, Agreements, Name Change, and Partnerships - Analyst Notes on Johnson & Johnson, Furiex Pharmaceuticals, Select Medical, CTI and Hill-Rom 6:00 a.m. June 13, 2014 - PR Newswire - PRF
CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Initiates Randomized Phase 2 Trial Evaluating Tosedostat plus Cytarabine for Older Patients with AML or High-Risk MDS 1:30 a.m. June 12, 2014 - PR Newswire - PRF
Cell Therapeutics, Inc. Announces Change of Name to CTI BioPharma Corp. 1:30 a.m. May 30, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Cell Therapeutics, Inc. Regarding Possible Breaches of Fiduciary Duty 12:52 p.m. May 29, 2014 - PR Newswire - PRF
CollabRx's Mobile App Simplifies Cancer Treatment Options 10:46 a.m. May 29, 2014 - ACCESSWIRE
Cell Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference 1:30 a.m. May 29, 2014 - PR Newswire - PRF
Top Gainers on the Move -- Research on Aeropostale, FirstEnergy, Cell Therapeutics, and Dyax 5:00 a.m. May 28, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma 9:15 a.m. May 6, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼